RCGP curriculum - Introducing the GP curriculum
Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more
Under the Scottish programme, which will be rolled out to all aged 50–74 from June, patients with a weakly positive guaiac faecal occult blood test (FOBT) will undergo the more sensitive faecal immunochemical test (FIT) before colonoscopy.
In England, which began roll-out of its screening programme in April 2006, a weakly positive FOBT is followed by a repeat FOBT. Colonoscopy then follows.
Wales plans to begin roll-out of a similar scheme in April. Northern Ireland is working towards introducing a screening programme in 2009.
Last year, researchers from the Scottish Bowel Cancer Screening Laboratory in Dundee showed that using FIT in this way could reduce the need for colonoscopy by 30 per cent (GP, 13 January 2006).
The latest research showed similar results for a form of FIT that uses a card, rather than a sample tube to collect the samples.
In the study of 558 patients who submitted samples for initial FOBT, the two-tier approach to follow-up had sensitivity of 96 per cent and specificity of 59 per cent.
Lead researcher Professor Callum Fraser said the card is ‘more convenient and more stable’ than the tube method. The samples are stable for up to 30 days, rather than seven or eight days.
Costs will also be halved when postage and packing is taken into account, said Professor Fraser.
Chairman of the Primary Care Society for Gastroenterology Dr Richard Stevens said: ‘Colonoscopy is not without pain for the patient.’
Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more
Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more
Dr Sathya Naidoo explains the criteria that are required for completing iMAP. Read more
Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more
Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more
Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more
Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more
Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more
Comments
Only registered users may comment. Log in now or register for a free account.